# Level 2 Summary

| Profile | Rank | Match | Score | Confidence | Why |
|---|---:|---|---:|---:|---|
| p1 | 1 | Marcus Chen | 0.6354 | 0.6958 | Amara Okafor ↔ Marcus Chen: high strategic complementarity, both sides show near-term execution readiness. Recommended for a high-value intro based on product-investor-regulatory fit. |
| p1 | 2 | James Whitfield | 0.5198 | 0.6303 | Amara Okafor ↔ James Whitfield: high strategic complementarity. Recommended for a high-value intro based on product-investor-regulatory fit. |
| p1 | 3 | Dr. Elena Vasquez | 0.4204 | 0.6608 | Amara Okafor ↔ Dr. Elena Vasquez: both sides show near-term execution readiness. Recommended for a high-value intro based on product-investor-regulatory fit. |
| p2 | 1 | Dr. Elena Vasquez | 0.6526 | 0.6961 | Marcus Chen ↔ Dr. Elena Vasquez: high strategic complementarity, both sides show near-term execution readiness. Recommended for a high-value intro based on product-investor-regulatory fit. |
| p2 | 2 | Amara Okafor | 0.6354 | 0.6958 | Marcus Chen ↔ Amara Okafor: high strategic complementarity, both sides show near-term execution readiness. Recommended for a high-value intro based on product-investor-regulatory fit. |
| p2 | 3 | Sophie Bergmann | 0.4974 | 0.6384 | Marcus Chen ↔ Sophie Bergmann: high strategic complementarity. Recommended for a high-value intro based on product-investor-regulatory fit. |
| p3 | 1 | Marcus Chen | 0.6526 | 0.6961 | Dr. Elena Vasquez ↔ Marcus Chen: high strategic complementarity, both sides show near-term execution readiness. Recommended for a high-value intro based on product-investor-regulatory fit. |
| p3 | 2 | James Whitfield | 0.5345 | 0.6283 | Dr. Elena Vasquez ↔ James Whitfield: high strategic complementarity. Recommended for a high-value intro based on product-investor-regulatory fit. |
| p3 | 3 | Sophie Bergmann | 0.4341 | 0.6289 | Dr. Elena Vasquez ↔ Sophie Bergmann: adjacent priorities with potential non-obvious collaboration. Recommended for a high-value intro based on product-investor-regulatory fit. |
| p4 | 1 | Dr. Elena Vasquez | 0.5345 | 0.6283 | James Whitfield ↔ Dr. Elena Vasquez: high strategic complementarity. Recommended for a high-value intro based on product-investor-regulatory fit. |
| p4 | 2 | Amara Okafor | 0.5198 | 0.6303 | James Whitfield ↔ Amara Okafor: high strategic complementarity. Recommended for a high-value intro based on product-investor-regulatory fit. |
| p4 | 3 | Marcus Chen | 0.4482 | 0.6753 | James Whitfield ↔ Marcus Chen: adjacent priorities with potential non-obvious collaboration. Recommended for a high-value intro based on product-investor-regulatory fit. |
| p5 | 1 | Marcus Chen | 0.4974 | 0.6384 | Sophie Bergmann ↔ Marcus Chen: high strategic complementarity. Recommended for a high-value intro based on product-investor-regulatory fit. |
| p5 | 2 | Dr. Elena Vasquez | 0.4341 | 0.6289 | Sophie Bergmann ↔ Dr. Elena Vasquez: adjacent priorities with potential non-obvious collaboration. Recommended for a high-value intro based on product-investor-regulatory fit. |
| p5 | 3 | James Whitfield | 0.4111 | 0.5984 | Sophie Bergmann ↔ James Whitfield: high strategic complementarity. Recommended for a high-value intro based on product-investor-regulatory fit. |
